Screener
Find companies by what is true of them right now — the grade from their filings, the share price and how far it sits below its 52-week high, what it costs, what it pays and whether it lists options. Start from a named screen and adjust it.
Named screens
Adjust the screen
5,245 companies match
Showing 3,951–4,000 of 5,245
| Company | Grade | Price | Below high | P/E | Size | Yield | Options | Industry |
|---|---|---|---|---|---|---|---|---|
 FUSBFIRST US BANCSHARES INC | C | $16.62 | -2% | 12.22 | $84.7M | 1.7% | — | Banks Regional |
 IFRXInflaRx N.V. | F- | $1.17 | -57% | — | $84.6M | — | Monthly | Biotechnology |
| F- | $0.22 | -94% | — | $84.5M | — | Monthly | Auto Parts | |
| F- | $2.16 | -29% | — | $84.3M | 0.9% | Monthly | Oil Gas Midstream | |
| D- | $1.97 | -3% | — | $84.2M | — | — | Asset Management | |
| F | $1.46 | -67% | — | $83.9M | — | Monthly | Biotechnology | |
| F- | $9.37 | -50% | — | $83.5M | — | — | Specialty Retail | |
| D- | $2.84 | -71% | — | $83.3M | — | Monthly | Aerospace and Defense | |
| F- | $0.83 | -70% | — | $83M | — | Monthly | Medical Instruments and Supplies | |
| D | $0.97 | -60% | — | $82.8M | — | — | Software Application | |
| F- | $0.95 | -70% | — | $82.4M | — | Monthly | Building Products and Equipment | |
| F | $2.27 | -90% | — | $82.4M | — | — | Airports and Air Services | |
| Not rated | $3.47 | -70% | — | $82.3M | — | — | Biotechnology | |
| C | $14.34 | -14% | 10.39 | $82.2M | 5.3% | — | Banks Regional | |
| F | $3.83 | -44% | — | $82.2M | — | Monthly | Oil Gas Midstream | |
| D- | $1.29 | -60% | — | $81.8M | — | Monthly | Biotechnology | |
| A | $4.81 | -8% | 8.91 | $81.7M | 2.5% | Monthly | Banks Regional | |
| C | $2.21 | -23% | 21.73 | $81.7M | 18.1% | Monthly | Reit Mortgage | |
| B | $15.68 | -6% | 522.50 | $81.2M | 1.8% | — | Resorts and Casinos | |
| B | $16.36 | -10% | 71.11 | $81.1M | — | — | Specialty Business Services | |
| D+ | $10.26 | -3% | 9.77 | $81.1M | 5.7% | — | Asset Management | |
| D- | $0.98 | -19% | — | $81M | — | — | Broadcasting | |
| D- | $0.94 | -65% | — | $80.9M | — | — | Gold | |
| C | $0.52 | -79% | — | $80.7M | — | Monthly | Biotechnology | |
| D | $30.06 | -12% | — | $80.6M | — | — | Conglomerates | |
| Not rated | $0.43 | -88% | — | $80.6M | — | Monthly | Biotechnology | |
| F | $7.90 | -56% | — | $80.5M | — | — | Biotechnology | |
| F- | $6.29 | -22% | — | $80.3M | — | — | Specialty Chemicals | |
| Not rated | $10.52 | -4% | 52.93 | $80.3M | — | — | Shell Companies | |
| A | $3.21 | -48% | — | $80.3M | — | — | Capital Markets | |
| F- | $3.53 | -70% | — | $80.1M | — | — | Steel | |
| F | $0.59 | -81% | — | $80.1M | — | — | Electrical Equipment and Parts | |
| A- | $2.90 | -82% | — | $79.8M | — | — | Oil Gas Midstream | |
| F- | $0.17 | -92% | — | $79.6M | — | — | Conglomerates | |
| F | $4.05 | -65% | — | $79.5M | — | Monthly | Electronic Components | |
| F- | $0.93 | -85% | — | $79.4M | — | Monthly | Aerospace and Defense | |
| C- | $1.72 | -67% | — | $79.4M | — | Monthly | Electronic Components | |
| F- | $1.75 | -84% | — | $79.3M | — | — | Integrated Freight and Logistics | |
| Not rated | $0.35 | -75% | — | $79.1M | — | Monthly | Biotechnology | |
| C- | $0.83 | -61% | — | $78.8M | — | Monthly | Drug Manufacturers Specialty and Generic | |
| B+ | $2.00 | -22% | 2.20 | $78.2M | — | — | Marine Shipping | |
| B | $8.33 | -56% | 43.82 | $78.2M | — | — | Packaged Foods | |
| C- | $0.94 | -23% | — | $78.2M | — | — | Credit Services | |
| C | $17.16 | -6% | — | $78.1M | 2.3% | — | Banks Regional | |
| Not rated | $10.11 | -2% | — | $78M | — | — | Shell Companies | |
| D- | $5.50 | -38% | — | $78M | — | Monthly | Biotechnology | |
| F | $6.48 | -19% | 72.00 | $77.9M | — | — | Staffing and Employment Services | |
| F- | $1.96 | -47% | — | $77.9M | — | Monthly | Medical Devices | |
| A- | $1.08 | -60% | — | $77.9M | — | Monthly | Beverages Non Alcoholic | |
| F- | $1.47 | -79% | — | $77.8M | — | Monthly | Software Infrastructure |
A screen is a filter, not a recommendation. Every row met the stated test and nothing more — InspectStocks describes businesses from their own SEC filings and does not advise buying or selling anything.
